GBA Variants and Parkinson Disease: Mechanisms and Treatments
L Smith, AHV Schapira - Cells, 2022 - mdpi.com
The GBA gene encodes for the lysosomal enzyme glucocerebrosidase (GCase), which
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
Gangliosides in the brain: physiology, pathophysiology and therapeutic applications
Gangliosides are glycosphingolipids highly abundant in the nervous system, and carry most
of the sialic acid residues in the brain. Gangliosides are enriched in cell membrane …
of the sialic acid residues in the brain. Gangliosides are enriched in cell membrane …
The genetics of Parkinson's disease and implications for clinical practice
JO Day, S Mullin - Genes, 2021 - mdpi.com
The genetic landscape of Parkinson's disease (PD) is characterised by rare high penetrance
pathogenic variants causing familial disease, genetic risk factor variants driving PD risk in a …
pathogenic variants causing familial disease, genetic risk factor variants driving PD risk in a …
Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism
Mutations in GBA1, the gene encoding the lysosomal enzyme β-glucocerebrosidase
(GCase), which cause Gaucher's disease, are the most frequent genetic risk factor for …
(GCase), which cause Gaucher's disease, are the most frequent genetic risk factor for …
The role of lipids in Parkinson's disease
H Xicoy, B Wieringa, GJM Martens - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disease characterized by a progressive
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …
Glycosphingolipids and neuroinflammation in Parkinson's disease
K Belarbi, E Cuvelier, MA Bonte, M Desplanque… - Molecular …, 2020 - Springer
Parkinson's disease is a progressive neurodegenerative disease characterized by the loss
of dopaminergic neurons of the nigrostriatal pathway and the formation of neuronal …
of dopaminergic neurons of the nigrostriatal pathway and the formation of neuronal …
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
P García‐Sanz, J MFG Aerts… - Movement Disorders, 2021 - Wiley Online Library
Parkinson's disease (PD) is a progressive neurodegenerative disease where dopaminergic
neurons in the substantia nigra are lost, resulting in a decrease in striatal dopamine and …
neurons in the substantia nigra are lost, resulting in a decrease in striatal dopamine and …
Role of the endolysosomal system in Parkinson's disease
DJ Vidyadhara, JE Lee… - Journal of …, 2019 - Wiley Online Library
Parkinson's disease (PD) is one of the most common neurodegenerative disorders, affecting
1–1.5% of the total population. While progress has been made in understanding the …
1–1.5% of the total population. While progress has been made in understanding the …
Chaperone-mediated autophagy in neurodegenerative diseases: molecular mechanisms and pharmacological opportunities
YT Wang, JH Lu - Cells, 2022 - mdpi.com
Chaperone-mediated autophagy (CMA) is a protein degradation mechanism through
lysosomes. By targeting the KFERQ motif of the substrate, CMA is responsible for the …
lysosomes. By targeting the KFERQ motif of the substrate, CMA is responsible for the …
Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbance
OR Brekk, JR Honey, S Lee… - Proceedings of the …, 2020 - National Acad Sciences
Neurons are dependent on proper trafficking of lipids to neighboring glia for lipid exchange
and disposal of potentially lipotoxic metabolites, producing distinct lipid distribution profiles …
and disposal of potentially lipotoxic metabolites, producing distinct lipid distribution profiles …